Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about disclosure

06 Nov 2021 Evaluate

Aurobindo Pharma has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 05, 2021 for RPR Sons Advisors Mrs P Suneela Rani (Jointly holding).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..